Search

everythinglearnresearchcommunity

for

Search:↓

Taking 100 mg of DHEA daily for 16 weeks did not change metabolic and reproductive health significantly but increased certain ovarian markers with minimal side effects.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Feeding steers only Leucaena leucocephala causes severe health issues and poor weight gain.

The new delivery method for dutasteride is more effective and has fewer side effects.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Chronic cutaneous lupus erythematosus should be considered when acne treatments don't work.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

New treatments for lupus show promise, but more research is needed, especially for children.